| Ian C. Read
|
| Chairman of the Board, Chief Executive Officer
|
|
|
Age: 59
Bio & Compensation
- Reuters
|
| Frank A. D'Amelio
|
| Chief Financial Officer, Executive Vice President - Business Operations
|
|
|
Age: 55
Bio & Compensation
- Reuters
|
| Mikael Dolsten M.D., Ph.D.
|
| President - Worldwide Research and Development
|
|
|
Age: 54
Bio & Compensation
- Reuters
|
| Douglas M. Lankler
|
| Executive Vice President, Chief Compliance and Risk Officer
|
|
|
Age: 47
Bio & Compensation
- Reuters
|
| Amy W. Schulman
|
| Executive Vice President, General Counsel, Business Unit Lead - Consumer Healthcare
|
|
|
Age: 52
Bio & Compensation
- Reuters
|
| Charles H. Hill III
|
| Executive Vice President - Worldwide Human Resources
|
|
|
Age: 57
Bio & Compensation
- Reuters
|
| Freda C. Lewis-Hall M.D.
|
| Executive Vice President, Chief Medical Officer
|
|
|
Age: 58
Bio & Compensation
- Reuters
|
| Anthony J. Maddaluna
|
| Executive Vice President; President, Pfizer Global Supply
|
|
|
Age: 60
Bio & Compensation
- Reuters
|
| Laurie J. Olson
|
| Executive Vice President - Strategy, Portfolio and Commercial Operations
|
|
|
Age: 49
Bio & Compensation
- Reuters
|
| Sally Susman
|
| Executive Vice President - Policy, External Affairs and Communications
|
|
|
Age: 51
Bio & Compensation
- Reuters
|